pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Aug 11·1 min read
save

Health industry pushes back against Trump’s vaccine executive order

Aug 11, 2026·read at STAT ↗RegulatoryNegative

President Trump signed an executive order this week that would overhaul the federal childhood‑vaccination program, calling for fewer shots administered over a longer period.

The order specifically proposes breaking the combined measles‑mumps‑rubella (MMR) vaccine into three separate injections, despite the lack of scientific evidence and contrary to recommendations from health officials.

Leading doctors and pharmaceutical companies quickly voiced opposition, warning that the changes could endanger children and undermine established immunization schedules.

The backlash underscores the growing tension between the administration’s policy goals and the health‑care industry, which says any such changes must be grounded in data.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Trump is counting on the health care industry to remake vaccines. It’s pushing back instead”

read at STAT ↗
483 words · retrieved Aug 11
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADINGMoonLake ImmunotherapeuticsNOVARTIS
topics
Vaccines6Vaccine2Gene Therapy (AAV)

related stories

  • 2d agoNovo workforce down 13,000BioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Dec 22Fierce Biotech Fundraising Tracker '26: Sling reels in $123M; Circle gathers $92.5MFierce Biotech
  • Aug 31A winner, a loser, and a mid-stage signal from a major cardiology research conferenceSTAT
  • Aug 12STAT+: Neurocrine Biosciences rare disease drug possibly tied to safety issues, experts saySTAT